CLINICAL_TRIALS
trial_result
· 2018-08-14
Clinical Trial Update: Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men [Phase 3]
Summary
Phase 3 trial of oral testosterone undecanoate for male hypogonadism completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Clarus Therapeutics, Inc. | Conditions: Male Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2018-08-14